The achievements of pulmonology and the main directions of further improvement of medical care in the Russian Federation

The development of pulmonology in Russia is linked with the creative activity of the Scientific Research Institute of Pulmonology of the Federal Medico-Biological Agency (Research Institute of Pulmonology of the FMBA) and its scientific school.

The aim of the analytical review was to assess the role and contribution of the research team of the Research Institute of Pulmonology in improving the quality of medical care to the population of Russia.

Methods. The data of medical statistics of the Ministry of Health of the Russian Federation on morbidity and mortality of the population due to respiratory diseases (RD) from 2004 - 2018 are analyzed. The publications on scientific research conducted with the participation of employees of the Research Institute of Pulmonology for the period from 2005 to 2020 were studied.

Results. Over the past 30 years in Russia, with the participation of the staff of the Research Institute of Pulmonology, the state task of creating a system for organizing medical care for the population with RD has been successfully solved. The study and implementation of modern innovative approaches in the diagnosis, treatment and prevention of RD, the training of primary care physicians allowed to improve the quality of medical care to patients to the level of world standards. For the period from 2004 - 2018 the mortality of the population from RD 35.6% decrease was registered. During the pandemic of a new coronavirus infection, the use of pulmonology achievements in clinical practice contributed to a decrease in the frequency of deaths in people with COVID-19.

Conclusion. Currently, the Research Institute of Pulmonology of the FMBA of Russia retains a leading position in the country in the field of fundamental scientific research, innovative methods of diagnosis and treatment of RD, educational activities and training of specialists in the field of pulmonology.

1. Avdeev S.N. [Non-invasive ventilation in acute respiratory failure]. Pul’monologiya. 2005; (6): 37-54. DOI: 10.18093/0869-0189-2005-0-6-37-54 (in Russian).

2. Glybochko P.V., Fomin V.V., Moiseev S.V. et al. [Risk factors for the early development of septic shock in patients with severe COVID-19]. Terapevticheskiy arkhiv. 2020; 92 (11): 17-23. https://doi.org/10.26442/00403660.2020.11.000780 . (in Russian).

3. Yaroshetsky A.I., Gritsan A.I., Avdeev S.N. et al. [Diagnostics and intensive therapy of acute respiratory distress syndrome (Clinical guidelines of the “Federation of Anesthesiologists and Reanimatol-ogists of Russia”)]. Anesteziologiya ireanimatologiya. 2020; (2): 5-39. DOI: 10.17116/anaesthesiology20200215 (in Russian).

4. Tsareva N.A., Avdeev S.N., Neklyudova G.V. [A patient with severe idiopathic pulmonary arterial hypertension: is there a way out?]. Terapevticheskiy arkhiv. 2017; 89 (9):100—103. DOI: 10.17116/ter-arkh2017899100-103 (in Russian).

5. Glybochko P.V., Fomin V.V., Moiseev S.V. et al. [Clinical outcomes of patients with COVID-19 admitted for respiratory support to the intensive care units in Russia]. Klinicheskaya farmakologiya i terapiya. 2020; 29 (3): 25-36. DOI: 10.32756/0869-5490-2020-3-25-36 (in Russian).

6. Chernyak A.V., Avdeev S.N., Belevskiy A.S. et al. [Pulmonary function test in patients with idiopathic pulmonary fibrosis: data from the National Registry for Moscow and Moscow region]. Pul’monologiya. 2020; 30 (1): 31-41. DOI: 10.18093/0869-0189-2020-30-1-31-41 (in Russian).

7. Chernyak A.V., Neklyudova G.V., Krasovskiy S.A. et al. [Nitrogen leaching in multiple breathing and structural changes in the bronchopulmonary system in adult patients with cystic fibrosis]. Pul’monologiya. 2020; 30 (2): 193-203. DOI: 10.18093/0869-0189-2020-30-2-193-203 (in Russian).

8. Savushkina O.I., Cherniak A.V., Kryukov E.V. et al. [Pulmonary function after COVID-19 in early convalescence phase]. Meditsinskiy alfavit. 2020; (25): 7-12. DOI: 10.33667/2078-5631-2020-25-7-12 (in Russian).

9. Balionis O.I., Nikitin A.G., Aver’yanov A.V. [Genetic predictors of sarcoidosis course]. Prakticheskayapul’monologiya. 2019; (3): 48-55. Available at: http://www.atmosphere-ph.ru/modules/Magazines/articles//pulmo/pp_3_2019_48.pdf (in Russian).

10. Danilevskaya O.V., Sorokina A.V., Averianov A.V. et al. [Peculiarities of accomplishment of confocal laser endomicroscopy in distal airways and principles of morphometric analysis].Endoskopicheskaya khirurgiya. 2013; 19 (5): 28-36. Available at: https://www.mediasphera.ru/issues/endoskopicheskaya-khirurgiya/2013/5/031025-7209201356 (in Russian).

11. Averyanov A.V., Konoplyannikov A.G., Zabozlaev F.G. et al. [Comparative study of the effects of mesenchymal stem cells with different delivery methods in an experimental model of lung fibrosis]. Klinicheskaya praktika. 2018; 9 (4): 4-14. Available at: https://cyberleninka.ru/article/n/sravnitelnoe-issledovanie-effektov-mezenhimalnyh-stvolovyh-kletok-pri-razlichnyh-metodah-dostavki-v-eksperimentalnoy-modeli-fibroza/viewer (in Russian).

12. Krasovskiy S.A., Kashirskaya N.Yu., Chernyak A.V. et al. [Genetic characterization of cystic fibrosis patients in Russian Federation according to the National Register 2014]. Pul’monologiya. 2016; 26 (2): 133-151. DOI: 10.18093/0869-0189-2016-26-2-133-151 (in Russian).

13. Krasovskiy S.A., Amelina E.L., Chernyak A.V. et al. [Observational study of the use of 7% sodium chloride solution combined with 0.1% hyaluronic acid in therapy of adults with cystic fibrosis]. Meditsinskiy sovet. 2018; (21): 72-77. DOI: 10.21518/2079-701X-2018-21-72-77 (in Russian).

14. Voronina O. L., Ryzhova N. N., Kunda M. S. et al. Characteristics of the airway microbiome of cystic fibrosis patients. Biochemistry (Mosc.). 2020; 85 (1): 1-10. DOI: 10.1134/S0006297920010010.

15. Pershina E.S., Cherniaev A.L., Samsonova M.V. et al. [Comparison of the CT patterns and pulmonary histology in patients with COVID-19]. Meditsinskaya vizualizatsiya. 2020; 24 (3): 37-53. DOI: 10.24835/1607-0763-2020-3-37-53 (in Russian).

16. Samsonova M.V., Chernyaev A.L., Omarova Zh. R. et al. [Features of pathological anatomy of lungs at COVID-19]. Pul’monologiya. 2020; 30 (5): 519-532. DOI: 10.18093/0869-0189-2020-30-5-519-532 (in Russian).

17. Makarova M.A., Chernyaev A.L., Samsonova M.V. et al. [Isolated lung lesion in adults with langerhans cell histiocytosis (2 clinical cases)]. Prakticheskaya pul’monologiya. 2019; (4): 37-44. Available at: http://www.atmosphere-ph.ru/modules/Magazines/articles//pulmo/pp_4_2019_37.pdf (in Russian).

18. Nenasheva N.M., Aver’yanov A.V., Il’ina N.I. et al. [Comparative study оf biosimilar Genolar® clinical efficacy оп the randomized phase III study results]. Pul’monologiya. 2020; 30 (6): 782-796. DOI: 10.18093/0869-0189-2020-30-6-782-796 (in Russian).

19. Babak S.L., Gorbunova M.V., Golubev L.A. [Current detection and treatment of respiratory disorders during sleep in therapeutic practice]. Pul’monologiya. 2006; (5): 104-114. DOI: 10.18093/0869-0189-2006-5-104-114 (in Russian).

20. Voznesensky N.A. [Nitric oxide in rhinology]. Rossiyskaya rinologiya. 1999; (4): 25-29. Available at: http://rhinology.ru/docs/zhurnal/1999-4.pdf (in Russian).

21. Lisitsa A.V., Soodaeva S. K., Klimanov I. A., Averyanov A.V. [Useing drugs created on a phospholipid basis in pulmonological practice]. Prakticheskaya meditsina. 2013; 74 (5): 21-27. Available at: https://pt.booksc.org/book/36389152/22a17c (in Russian).

22. Soodaeva S.K., Klimanov I.A., Nikitina L.Yu. [Nitrosative and oxidative stresses in respiratory diseases]. Pul’monologiya. 2017; 27 (2): 262-273. DOI: 10.18093/0869-0189-2017-27-2-262-273 (in Russian).

23. Bystritskaya E.V., Bilichenko T.N. [An analysis of pneumonia morbidity in adults and children at Russian Federation, 2010-2014]. Pul’monologiya. 2017; 27 (2): 173-178. DOI: 10.18093/0869-0189-2017-27-2-173-178 (in Russian).

24. Bilichenko T.N., Tubekova M.A., Afanasieva M.V., Yachutlova I.L. [Prevalence and risk factors of bronchial asthma and other allergic diseases in adult population of Moscow]. Pul’monologiya. 2019; 29 (5): 555-563. DOI: 10.18093/0869-0189-2019-29-5-555-563 (in Russian).

25. Gruzdeva O.A., Bilichenko T.N., Baryshev M.A. et al. [The impact of vaccination against influenza and pneumococcal infection on the incidence of acute respiratory viral infections and community-acquired pneumonia in the Central Administrative District of Moscow]. Epidemiologiya i vaktsinoprofilaktika. 2021; 20 (2): 28-41. DOI: 10.31631/2073-3046-2021-20-2-28-41 (in Russian).

26. WHO. Global Adult Tobacco Survey Russian Federation 2016: Factsheet. Available at: https://www.euro.who.int/data/assets/pdf_file/0005/343319/-2016.pdf

27. Vasilieva O.S., Kuzmina L.P., Chernyak A.V. et al. [The role of occupational factors and individual susceptibility in the development and course of bronchopulmonary diseases]. Pul’monologiya. 2021; 31 (4): 463-468. DOI: 10.18093/0869-0189-2021-31-4-463-468 (in Russian).

28. Khubutia M.Sh., Chuchalin A.G., Abakumov M.M. et al. [The first lung transplantation at the N.V.Sklifosovsky Research Institute of Emergency Medicine]. Transplantologiya. 2011; (2-3): 5-9. DOI: 10.23873/2074-0506-2011-0-2-3-5-9 (in Russian).

29. Bilichenko T.N. [Epidemiology of coronavirus disease 2019 (COVID-19)]. Akademiya meditsiny i sporta. 2020; 1 (2): 14-20. DOI: 10.15829/1560-4071-2020-2-15 (in Russian).

30. Makarova M.A. [Specific laboratory diagnostics of a new coronavirus infection caused by SARS-CoV-2]. Astma i allergiya. 2020; (2): 2-7. Available at: http://www.atmosphere-ph.ru/modules/Magazines/articles/astma/Asthma_2_20_2.pdf (in Russian).

31. [The prevention, diagnosis and treatment of the new coronavirus infection 2019-nCoV. Temporary guidelines Ministry of Health of the Russian Federation]. Pul’monologiya. 2019; 29 (6): 655-672. DOI: 10.18093/0869-0189-2019-29-6-655-672 (in Russian).

32. Zabolotskikh I.B., Kirov M.Yu., Lebedinskii K.M. et al. [Anesthesia and intensive care for patients with COVID-19: Russian Federation of anesthesiologists and reanimatologists guidelines]. Vestnik inten-sivnoy terapii. 2021; (Suppl. 1): 9-143. DOI: 10.21320/1818-474X-2 021-S1-9-143 (in Russian).

33. Avdeev S.N., Tsareva N.N., Merzhoeva Z.M. et al. [Practical guidance for oxygen treatment and respiratory support of patients with COVID-19 infection before admission to intensive care unit]. Pul’monologiya. 2020; 30 (2): 151-163. DOI: 10.18093/0869-0189-2020-30-2-151-163 (in Russian).

34. Avdeev S.N. [Non-invasive ventilation in patients with novel coronavirus infection COVID-19]. Pul’monologiya. 2020; 30 (5): 679-687. DOI: 10.18093/0869-0189-2020-30-5-679-687 (in Russian).

35. Aver’yanov A.V., Klypa T.V., Balionis O.I. et al. [Inhaled surfactant in patients with COVID-19 who took high-flow oxygen therapy: the results of a retrospective analysis]. Remedium. 2020; (7-8): 84-88. DOI: 10.21518/1561-5936-2020-7-8-84-88 (in Russian).

36. Aisanov Z.R., Kalmanova E.N., Kameneva M.Yu. et al. [Recommendations of the Russian Respiratory Society for conducting functional studies of the respiratory system during the COVID-19 pandemic. Version 1.1 from 19.05.2020]. Prakticheskaya pul’monologiya. 2020; (1): 104-106. Available at: http://www.atmosphere-ph.ru/modules/Magazines/articles//pulmo/pp_1_2020_104.pdf (in Russian).

37. Zaitsev A.A., Savushkina O.I., Chernyak A.V. et al. [Clinical and functional characteristics of patients who recovered from the novel coronavirus infection (COVID-19)]. Prakticheskaya pul’monologiya. 2020; (1): 78-81. Available at: http://www.atmosphere-ph.ru/modules/Magazines/articles//pulmo/pp_1_2020_78.pdf (in Russian).

38. Kryukov E.V., Savushkina O.I., Malashenko M.M. et al. [Influence of complex medical rehabilitation on pulmonary function and quality of life in patients after COVID-19]. Byulleten’fiziologii ipatologii dykhaniya. 2020; (78): 84-91. DOI: 10.36604/1998-5029-2020-78-84-91 (in Russian).

39.